BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15046218)

  • 21. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?
    Clark W; Golkar F; Luberice K; Toomey P; Paul H; Marcadis A; Okpaleke C; Vice M; Hernandez J; Alsina A; Rosemurgy AS
    Am J Surg; 2011 Nov; 202(5):561-4. PubMed ID: 21944293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures.
    Otal P; Smayra T; Bureau C; Peron JM; Chabbert V; Chemla P; Joffre F; Vinel JP; Rousseau H
    AJR Am J Roentgenol; 2002 Jan; 178(1):141-7. PubMed ID: 11756108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts.
    Jung HS; Kalva SP; Greenfield AJ; Waltman AC; Walker TG; Athanasoulis CA; Wicky ST
    J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
    Wang X; Luo X; Zhao M; Song J; Li X; Yang L
    Dig Dis Sci; 2020 Oct; 65(10):3032-3039. PubMed ID: 31853780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience.
    Rossi P; Salvatori FM; Fanelli F; Bezzi M; Rossi M; Marcelli G; Pepino D; Riggio O; Passariello R
    Radiology; 2004 Jun; 231(3):820-30. PubMed ID: 15118117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
    Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device.
    Lauermann J; Potthoff A; Mc Cavert M; Marquardt S; Vaske B; Rosenthal H; von Hahn T; Wacker F; Meyer BC; Rodt T
    Cardiovasc Intervent Radiol; 2016 Apr; 39(4):547-56. PubMed ID: 26404629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis.
    Cejna M; Peck-Radosavljevic M; Thurnher SA; Hittmair K; Schoder M; Lammer J
    Radiology; 2001 Nov; 221(2):437-46. PubMed ID: 11687688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
    Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
    AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent.
    Otal P; Rousseau H; Vinel JP; Ducoin H; Hassissene S; Joffre F
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):183-8. PubMed ID: 10082107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience.
    Gupta AC; Wang W; Shah C; Sands MJ; Bullen J; Remer EM; Bayona PM; Carey W; Kapoor B
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1723-1731. PubMed ID: 28512687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M; Peck-Radosavljevic M; Thurnher S; Schoder M; Rand T; Angermayr B; Lammer J
    Cardiovasc Intervent Radiol; 2002; 25(5):365-72. PubMed ID: 11981612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R; Konda D; Simonetti G
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dacron-covered stent-grafts in transjugular intrahepatic portosystemic shunts: initial experience.
    Lau CT; Scott M; Stavropoulos SW; Soulen MC; Solomon JA; Clark TW
    Radiology; 2005 Aug; 236(2):725-9. PubMed ID: 16000648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular Intrahepatic Portosystemic Shunt Flow Reduction with Adjustable Polytetrafluoroethylene-Covered Balloon-Expandable Stents Using the "Sheath Control" Technique.
    Blue RC; Lo GC; Kim E; Patel RS; Scott Nowakowski F; Lookstein RA; Fischman AM
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):935-9. PubMed ID: 26627484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Han J; Huang Q; Li N; Li J
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):701-8. PubMed ID: 20703849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.